- Home
- SCOR vs SER Comparison
SCOR vs SER Comparison
Compare SCOR & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCOR
- SER
- Stock Information
- Founded
- SCOR 1999
- SER 2017
- Country
- SCOR United States
- SER United States
- Employees
- SCOR N/A
- SER N/A
- Industry
- SCOR Business Services
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- SCOR Consumer Discretionary
- SER Health Care
- Exchange
- SCOR Nasdaq
- SER Nasdaq
- Market Cap
- SCOR 37.1M
- SER 42.0M
- IPO Year
- SCOR 2007
- SER 2018
- Fundamental
- Price
- SCOR $6.87
- SER $4.20
- Analyst Decision
- SCOR
- SER Strong Buy
- Analyst Count
- SCOR 0
- SER 2
- Target Price
- SCOR N/A
- SER $13.00
- AVG Volume (30 Days)
- SCOR 15.0K
- SER 27.6K
- Earning Date
- SCOR 11-04-2025
- SER 11-11-2025
- Dividend Yield
- SCOR N/A
- SER N/A
- EPS Growth
- SCOR N/A
- SER N/A
- EPS
- SCOR N/A
- SER N/A
- Revenue
- SCOR $358,940,000.00
- SER $130,000.00
- Revenue This Year
- SCOR $3.45
- SER $134.46
- Revenue Next Year
- SCOR $2.59
- SER N/A
- P/E Ratio
- SCOR N/A
- SER N/A
- Revenue Growth
- SCOR 0.77
- SER N/A
- 52 Week Low
- SCOR $4.39
- SER $3.70
- 52 Week High
- SCOR $10.18
- SER $7.92
- Technical
- Relative Strength Index (RSI)
- SCOR 42.77
- SER 32.99
- Support Level
- SCOR $6.42
- SER $3.70
- Resistance Level
- SCOR $7.89
- SER $4.45
- Average True Range (ATR)
- SCOR 0.50
- SER 0.32
- MACD
- SCOR -0.09
- SER -0.09
- Stochastic Oscillator
- SCOR 23.81
- SER 20.72
About SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each across media platforms. The platforms it measures include televisions, mobile devices, computers, tablets, CTV devices, and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada, and other regions. It provides solutions for the automotive, digital media, financial services, pharmaceutical, retail, technology, travel, and other industries.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.